연구동향 분석

The Evolving Epidemiology of Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae Strains Isolated from Adults in Crete, Greece, 2009–2016

Sofia Maraki Viktoria Eirini Mavromanolaki Dimitra Stafylaki George Hamilos George Samonis 2018년

논문상세정보
인용/피인용

' The Evolving Epidemiology of Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae Strains Isolated from Adults in Crete, Greece, 2009–2016' 의 참고문헌

  • Trimethoprim-sulfamethoxazole prophylaxis and antibiotic nonsusceptibility in invasive pneumococcal disease
    Soeters HM [2012]
  • The spectrum of invasive pneumococcal disease in adults in the XXI century
    Falcó V [2013]
  • The herd effects of infant PCV7/PCV13 sequential implementation on adult invasive pneumococcal disease, six years post implementation; a nationwide study in Israel
  • The epidemiology of invasive pneumococcal disease in older adults in the post-PCV era. Has there been a herd effect?
    Corcoran M [2017]
  • The burden of PCV13 serotypes in hospitalized pneumococcal pneumonia in Spain using a novel urinary antigen detection test. CAPA study
    Menéndez R [2017]
  • Streptococcus pneumoniae colonisation: the key to pneumococcal disease
    Bogaert D [2004]
  • Serotype/serogroup-specific antibiotic non-susceptibility of invasive and non-invasive Streptococcus pneumoniae, Switzerland, 2004 to 2014
    Hauser C [2016]
  • Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites
    Feikin DR [2013]
  • Serotype distribution and antimicrobial susceptibility of USA Streptococcus pneumoniae isolates collected prior to and post introduction of 13-valent pneumococcal conjugate vaccine
    Mendes RE [2014]
  • Serotype distribution and antimicrobial resistance of adult Streptococcus pneumoniae clinical isolates over the period 2001-2008 in Crete, Greece
    Maraki S [2010]
  • Serotype 3 remains the leading cause of invasive pneumococcal disease in adults in Portugal (2012-2014) despite continued reductions in other 13-valent conjugate vaccine serotypes
    Horácio AN [2016]
  • Recommendations for pneumococcal immunization outside routine childhood immunization programs in Western Europe
    Castiglia P [2014]
  • Rates of pneumococcal disease in adults with chronic medical conditions
    Shea KM [2014]
  • Public health impact of pneumococcal conjugate vaccine infant immunization programs: assessment of invasive pneumococcal disease burden and serotype distribution
    Izurieta P [2018]
  • Principles and Practice of Infectious Diseases
    Musher DM [2010]
  • Performance standards for antimicrobial susceptibility testing; twenty-sixth informational supplement
  • Outpatient antibiotic use in Europe and association with resistance: a cross-national database study
    Goossens H [2005]
  • National Meningitis Reference Laboratory Data 1993–2015
  • Interim results of an ecological experiment - Conjugate vaccination against the pneumococcus and serotype replacement
  • Indirect (herd) protection, following pneumococcal conjugated vaccines introduction: A systematic review of the literature
    Tsaban G [2017]
  • Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia
    Rodrigo C [2015]
  • Immunization, Vaccines and Biologicals - Data, statistics and graphics
  • Herd protection induced by pneumococcal conjugate vaccine
    Klugman KP [2014]
  • Healthcare utilization and cost of pneumococcal disease in the United States
    Huang SS [2011]
  • Guidelines for the management of adult lower respiratory tract infections--full version
    Woodhead M [2011]
  • Genomic identification of a novel co-trimoxazole resistance genotype and its prevalence amongst Streptococcus pneumoniae in Malawi
    Cornick JE [2014]
  • Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques
    Said MA [2013]
  • Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015
  • Efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) versus that of 7-valent PCV (PCV7) against nasopharyngeal colonization of antibiotic-nonsusceptible Streptococcus pneumoniae
    Dagan R [2015]
  • Effects of infant pneumococcal conjugate vaccination on serotype distribution in invasive pneumococcal disease among children and adults in Germany
  • Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance
    Moore MR [2015]
  • Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study
    Waight PA [2015]
  • Effect of age on the manifestations and outcomes of invasive pneumococcal diseases in adults
    Marrie TJ [2018]
  • Distribution of Streptococcus pneumoniae serotypes among non-sterile isolates from adults 18 years and older in Europe and the United States, 2014-2015
  • Distribution of Streptococcus pneumoniae serotypes among global population
  • Differences in the burden of all-cause CAP due to PCV13 serotypes based in the different use of vaccine by regions in Spain (the CAPA study)
    España PP [2018]
  • Demonstration of the herd effect in adults after the implementation of pneumococcal vaccination with PCV13 in children
    Hays C [2017]
  • Clinical and economic burden of community-acquired pneumonia among adults in Europe
    Welte T [2012]
  • Antibiotic susceptibility rates of invasive pneumococci before and after the introduction of pneumococcal conjugate vaccination in Germany
    Imöhl M [2015]